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Abstract: Various techniques and interventions have been developed in an effort to obviate gas-
trointestinal anastomotic leaks. This review is intended to delineate potential modifications that can 
be made to reduce the risk of anastomotic leaks following gastrointestinal surgery. It may also serve 
to aid in identifying patients who are at increased risk of anastomotic leak. Modifiable risk factors 
for leak discussed include malnutrition, smoking, steroid use, bowel preparation, chemotherapy, 
duration of surgery, use of pressors, intravenous fluid administration, blood transfusion, and sur-
gical anastomotic technique. Based upon literature review, operative techniques should include 
minimizing operative time, reducing ischemia, and utilizing stapled anastomoses. Buttressing of 
anastomoses with omentum has proven utility for esophageal surgery. Further recommendations 
include 5–7 days of immune-modifying nutritional supplementation for malnourished patients, 
discontinuation of smoking in the perioperative period, limiting steroid use, utilization of oral 
antibiotic preparation for colorectal surgery, avoidance of early operations (,4 weeks) following 
chemotherapy, limiting pressor use, and the utilization of goal-directed fluid management.
Keywords: anastomosis, anastomotic, leak, dehiscence, gastrointestinal, complications
Background
Anastomotic leakage has been the bane of intestinal surgery for over a century. Various 
surgical techniques and interventions have been developed in an effort to obviate these 
leaks. Unfortunately, to date, the issue remains and will likely persist into the foreseeable 
future. Anastomotic leaks are often difficult to manage and add a degree of frustration to 
surgeons. They have a great clinical impact as well. Patients with anastomotic leaks have 
higher lengths of stay, higher mortality rates, higher readmission rates, more reoperations, 
and an overall greater impact on quality of life.1 Patients who have anastomotic leaks 
following cancer operations have a higher risk of distant recurrence.2 These patients also 
experience large delays in receiving indicated adjuvant chemotherapy.3 In addition, in 
the new world of tighter health care spending, we must also be aware that anastomotic 
leaks have a significant financial impact on hospitals as well.4
This review is intended to delineate the potential modifications that can be made to 
reduce the risk of anastomotic leaks following gastrointestinal (GI) surgery. It may also 
serve to aid in identifying patients who are at increased risk of anastomotic leak.
Risk factors for anastomotic leak
In general, anastomotic leaks occur in varying frequencies depending upon the tis-
sue that is being anastomosed (Table 1).4–16 As GI surgeons, these rates are of utmost 
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importance as they have significant impact on our index of 
suspiciion for detection of leaks. Leak rates are high for 
very proximal (esophageal) and very distal (low rectal) 
anastomoses.
There are clearly many patient and care factors that 
contribute to anastomotic leaks. Unfortunately, many risk 
factors are not under the control of the medical team and are 
relatively unalterable (Table 2). When faced with patients 
who have these risk factors, leak rates will clearly be higher. 
It should go without saying that in these circumstances, 
surgeons should have a high index of suspicion for leak, 
consider avoiding anastomoses and using end stomas (where 
appropriate) or consider placing proximal diverting stomas 
(where appropriate).
Adjustable risk factors for 
anastomotic leak
There are a number of factors that may be adjustable and lead 
to lower rates of anastomotic leak (Table 3). Some interven-
tions to address these issues may be difficult to undertake 
while others can be utilized as standard practice for many 
surgeons. These factors are discussed further in the Modify-
ing patient factors to reduce anastomotic leaks section.
Modifying patient factors to reduce 
anastomotic leaks
Nutrition
It is clear that nutritionally depleted patients are more prone 
to complications, and there have been a number of studies, 
which have shown that preoperative weight loss is associated 
with increased risk of anastomotic leakage.4,17–19 Studies 
evaluating nutritional supplementation tend to evaluate over-
all complications (including anastomotic leak), but few break 
out anastomotic leak alone. In addition, we must strongly 
consider the type (parenteral vs enteral) and timing (preopera-
tive or postoperative) of nutritional supplementation.
There is evidence that total parenteral nutrition (TPN) 
administration may reduce overall complications of surgery 
in malnourished patients.20 This has been evaluated a num-
ber of times in malnourished patients undergoing gastric 
surgery, and it does appear that the addition of TPN reduces 
complications in this patient population.21 However, these 
studies mainly evaluate the administration of TPN in the 
postoperative period. Most practitioners are well-aware of the 
benefits of TPN in patients who are unable to tolerate a diet 
in the postoperative period. However, it is unclear if there is 
Table 1 incidence of anastomotic leaks
Type of anastomosis Incidence of 
anastomotic leak
esophageal 9.6%–14%
Stomach 1.1%–3.3%
Small intestine 1%–3.8%
ileocolic 2%–6.5%
Colocolonic 3%–5.4%
Colorectal 7%–13%
ileorectal 5%–19%
Notes: Data from these studies.4–16,74
Table 2 Nonadjustable risk factors for anastomotic leak
Abdominal ascites Obesity* Radiation therapy
Advanced malignancy 
(metastatic disease)
History of 
cardiovascular  
disease
Renal failure
Alcohol abuse* Previous history of 
smoking
Site of anastomosis 
(esophageal and low rectal 
have the highest risk)
Anemia
Diabetes Male sex
emergency surgery Medical comorbidity 
(high ASA)
Tumor size
Note: *Denotes potentially partially adjustable risk factor.
Abbreviation: ASA, American Society of Anesthesiologists Physical Status 
Classification System.
Table 3 Adjustable risk factors for anastomotic leak
Risk factor Recommendation
Malnutrition 5–7 days of immune-modifying nutritional 
supplementation recommended for 
malnourished patients. TPN is only indicated 
for postoperative patients unable to tolerate 
enteral feeding
Smoking Discontinuation of smoking (4–8 weeks of 
cessation preop and for 4 weeks postop)
Steroid use if possible, discontinue use prior to surgery 
(single dose on induction of anesthesia is 
acceptable)
Bowel preparation Use of oral antibiotic preparation for 
colorectal surgery
Chemotherapy Avoid early operations (,4 weeks) 
following chemotherapy but long-term delay 
times (.7 weeks) are likely unnecessary
Surgery duration Minimize the length of surgery
Pressor agents Limit use of pressors and when pressors are 
necessary consider proximal diversion or 
end stoma in colorectal surgery
Intravenous fluids/blood 
transfusion
Utilize goal-directed fluid management and 
restrictive blood transfusion guidelines
Anastomotic technique Limit tension, optimize perfusion, use the 
technique most comfortable with (stapled 
may be preferable)
Buttressing anastomosis Omentoplasty should be utilized for 
esophageal anastomoses after transhiatal 
esophagectomy
Abbreviations: postop, postoperative; preop, preoperative; TPN, total parenteral 
nutrition.
 
O
pe
n 
Ac
ce
ss
 S
ur
ge
ry
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
14
7.
14
0.
23
3.
16
 o
n 
28
-M
ar
-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
 Open Access Surgery 2016:9 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
7
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any benefit to preoperative parenteral supplementation. The 
data are sparse and in at least one study on the preoperative 
administration of TPN in malnourished ulcerative colitis 
patients undergoing colectomy, TPN did not improve anas-
tomotic leak rates.22
In a recent Cochran review on the subject, the authors 
concluded that although there is some evidence that preop-
erative parenteral nutrition can reduce complications after 
GI tract surgery in malnourished patients, the data may not 
be applicable to most patients.23 Currently, it is difficult to 
make sweeping recommendations regarding preoperative 
TPN administration except in cases where patients are unable 
to tolerate enteral nutrition.
At the same time, there is a growing body of evidence 
that suggest enteral nutritional supplementation may aid in 
reducing surgical complications.24 There is clearly a body of 
evidence that demonstrates decreased complication rates in 
malnourished patients when they undergo preoperative nutri-
tional supplementation.24,25 Further, there is growing sentiment 
that immune-enhancing nutrition may be even more beneficial 
for the malnourished patient.26 Immune-enhancing enteral 
nutrition typically entails a high-protein nutritional supple-
ment with the addition of “immune-enhancing” components, 
which have been shown to augment the immune response 
(glutamine, arginine, n-3 fatty acids, and ribonucleic acids).
One would imagine that there is a possibility that these 
immune-enhancing formulas might be beneficial to non-
malnourished patients as well. To address this question, there 
have been a number trials of immune-enhancing supplements 
in non-malnourished patients undergoing upper GI surgery 
and, to date, there does not appear to be an advantage to 
supplementation in non-malnourished patients.27
To summarize, there are strong recommendations for 
the administration of immune-enhancing oral supplementa-
tion for 5–7 days preoperatively in malnourished patients in 
an effort to reduce complications.28 Although anastomotic 
leakage has not been individually evaluated in most studies, 
major morbidity and mortality has and, it is safe to extrapolate 
that lower infection rates and complications encompasses 
anastomotic leakage as well.
Smoking
Smoking has been shown to be a risk factor for anastomotic 
leak in multiple studies on various types of GI anastomo-
ses.1,29–31 This increase has been shown to be approximately 
fourfold compared to nonsmokers.32 As surgeons, we are 
often left with the difficult task of counselling smoking 
cessation. Unfortunately, short-term smoking cessation has 
not been shown to reduce anastomotic leak complications.33,34 
Therefore, recommendations for preoperative smoking 
cessation entail discontinuation of smoking for 4–8 weeks 
prior to surgery and through the postoperative healing phase 
as well.35,36 This may be something of a “tough sell” but, for 
the motivated patient undergoing semi elective surgery, it 
is well-worth counselling. The greatest success will likely 
come from practitioners who utilize a smoking cessation 
team rather than a go-it-alone strategy.37
Medications
Steroids/immune modulators
There are myriad publications describing the use of steroid is 
an independent risk factor for impaired healing of many types 
of wounds across multiple specialties. In animal models, ste-
roid administration over short-term and long-term at both high 
and low dosages result in impaired intestinal healing.38,39 Not 
surprisingly, long-term administration of high-dose steroids 
has been shown to cause the most impairment in healing.40 
In systemic analysis, steroids have been shown to increase 
anastomotic leak rate.41 Muddying the waters a bit is a study 
on patients with inflammatory bowel disease, which demon-
strated no increase in anastomotic leak in patients who are on 
low- and high-dose steroids at the time of surgery.39,42 Bearing 
this in mind, the association between impaired wound healing 
has been well established and, if at all possible, patients should 
be steroid free at the time of intestinal surgery.43
Increasingly, our patients are being given steroids upon 
induction of anesthesia. As part of enhanced recovery path-
way, it is becoming standard to administer a single dose of 
dexamethasone perioperatively to reduce nausea. To date, 
this practice does not appear to cause an impairment in wound 
healing but further study is pending.44,45 The DREAMS trial 
to analyze the potential risk of dexamethasone on GI surgery 
completed recruitment of over 1,300 patients in the UK in 
January 2015, and the final data analysis is pending at the 
time of this publication.46
Finally, it is worth mentioning anastomotic leak risk 
with biologic therapy (anti-tumor necrosis factor agents). 
Logically, one would assume that these agents would cause 
an increase in anastomotic leakage. To date, there have been 
multiple retrospective studies on the subject. In some stud-
ies, it appears that biologic therapy increases postoperative 
complications while others have reached the opposite con-
clusion. Currently, it is unclear if biologic therapy does, in 
fact, cause an increase in anastomotic leak rates.47–50 Until 
more definitive data are available, no clear recommendation 
regarding these agents can be made.
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Chemotherapy
Preoperative chemotherapy and radiation therapy are most 
commonly utilized for esophageal and rectal cancers. 
Therefore, these locations of GI anastomoses are the most 
studied. Although some have reported no increase in anas-
tomotic leak in colorectal surgery following chemoradiation 
therapy,51 others have demonstrated that there is evidence that 
preoperative chemotherapy increases the risk of anastomotic 
leak in colorectal surgery.1,52 At the same time, neoadjuvant 
chemotherapy has not been shown to increase anastomotic 
leak rate in esophageal surgery.53–55 Although logically, one 
would assume there would be an association between neo-
adjuvant therapy and anastomotic leak, to date, there is no 
consensus about this relationship.
Some have considered the possibility that it is the timing 
of resection following neoadjuvant therapy that may have 
influence on anastomotic leak. In one study evaluating the 
timing of rectal resection after neoadjuvant chemoradiation 
therapy, there was no difference in leak rate between patients 
who had earlier vs later surgery following therapy (,7 vs 
.7 weeks).56 In a similar study on esophagectomy patients, 
there was also no difference in earlier vs later surgery fol-
lowing chemoradiation therapy either (,8 vs .8 weeks).57 
From these studies, we may be able to conclude that longer 
wait times are unlikely to reduce the risk of anastomotic 
leakage.
In addition to neoadjuvant therapy, the newest forms of 
chemotherapy are causing increasing concerns for surgery. 
There have been a number of reports of late anastomotic leaks 
following the administration of vascular endothelial growth 
factor (VEGF) inhibitors (eg, bevacizumab).58 In a recent 
trial on patients treated with neoadjuvant chemotherapy 
(with bevacizumab) there was a higher than the expected 
anastomotic leak rate.59 These particular chemotherapeutic 
agents pose a particular challenge for surgeons. Current 
recommendations are to hold VEGF inhibitors a minimum 
of 28 days prior to and 28 days after intestinal surgery to 
reduce the risk of anastomotic leakage.60,61 However, others 
have pointed out that VEGF inhibitors may be active up to 
12 weeks following administration and have recommended 
delaying surgery longer.1
NSAiDS
There are emerging data, which suggest that nonsteroidal 
anti-inflammatory drugs (NSAIDs) may contribute to anasto-
motic leaks. This issue has gained importance with the emer-
gence of early recovery bundles following GI surgery. Initial 
evidence in 2009 pointed to an increase in leaks from 3.3% 
to 15.1% with the addition of celecoxib, but this finding was 
with small numbers in a retrospective evaluation.62 However, 
it was further supported by another retrospective study on 
leaks, which identified an increase in leak rate from 7.6% to 
13.2% with NSAID use a few years later.63 Studies continue 
to find an association between NSAIDS and leaks.64 Interest-
ingly, in rat models, the addition of the NSAID carprofen 
significantly impaired the healing in ileal anastomoses (but 
not colocolonic) in two studies.65,66 Of course, there have also 
been papers that have concluded that there is no increase in 
anastomotic leak with NSAID usage.67,68 In a recent meta-
nalysis of NSAID usage and anastomotic leaks, the authors 
concluded that most studies, which indicate an association 
of NSAIDs with anastomotic leak are flawed but, that there 
is still concern regarding NSAID use and leak.69 It is this 
thought that has prompted prospective multicenter studies 
on the topic, which are currently underway.70
Unfortunately, to date, we can draw no clear conclusion 
about the association of NSAIDS and anastomotic leakage. 
It is likely to remain a hot topic as surgeons continue to bal-
ance the push for early discharge, cost savings, and enhanced 
recovery against potential increased morbidity, which may 
be associated with some of these regimens.
Medical therapy/future research
Although we do not currently possess medications/therapies 
that have been proven to improve GI wound healing and 
decrease anastomotic leaks, there are numerous ongoing 
studies investigating potential therapeutic possibilities. 
Based primarily on animal models, strategies include local 
application (topical placement, injection at anastomotic site, 
or coated suture materials) or systemic administration (intra-
venous, subcutaneous, and intraperitoneal) of growth factors 
directed specifically at the phases of intestinal healing.71 This 
burgeoning field may become increasingly relevant as we 
work to leverage technology to reduce anastomotic leaks.
Technical considerations for 
reducing anastomotic leaks
Stapled vs handsewn anastomosis
Disputes over the superiority of either handsewn or stapled 
anastomoses have been going on since the advent of stapled 
techniques. In almost all fora, there does not appear to be 
clear evidence of superiority with regard to anastomotic 
leak. A recent metanalysis of emergency GI surgery found 
no significant difference between stapled and handsewn 
anastomoses. The authors concluded that surgeons should 
use the technique of their choice.72 A recent Cochrane review 
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on colorectal anastomoses also found no difference between 
handsewn and stapled anastomoses.73
Interestingly, there are a few studies from the 1990s, 
which demonstrated a higher anastomotic leak rate in 
cancer surgeries following ileocolic resection with hand-
sewn anastomoses.74,75 However, more recent studies have 
failed to identify a difference in leak rate between the two 
techniques.76 In gastric bypass surgery, there has also been 
no demonstration of reduced leak with either technique in 
Roux-en-Y anastomoses77 nor has a difference been seen for 
ileostomy closure.78,79
Although there does not appear to be any major difference 
in anastomotic leak rate with stapled vs handsewn anastomo-
ses (with the potential exception of ileocolic anastomoses for 
cancer demonstrated in the 1990s). A number of authors had 
pointed out the advantages of faster surgery with the lower 
obstruction rate when stapled anastomoses are made.78,80 
In the end, the decision of type of anastomosis is likely a 
matter of surgeon preference as the techniques appear to be 
essentially equivalent with regard to leak rate.
Bioabsorbable staple-line reinforcement
The use of bioabsorbable staple-line reinforcing material 
is appealing to some. A number of reinforcing materials 
placed on anastomotic staplers are currently on the market. 
Although studies have shown that these reinforcements are 
safe, and there have been a number of randomized studies on 
the subject, to date, there have been no compelling studies, 
which have demonstrated a decrease in anastomotic leak 
rates when they are used.81–83 Consequently, advocates of 
bioabsorbable staple-line reinforcement should likely site 
potential reduction in staple line anastomotic stricture (which 
has been demonstrated) as their impetus for use rather than 
decreasing leak rate.84,85
Suture reinforcement
A number of authors have advocated placing reinforcing 
sutures about an anastomosis. There sutures are typically 
placed around the anastomosis, but intraluminal reinforce-
ment with sutures has also been described.86,87 To date, there 
is no compelling evidence indicating that suture reinforce-
ment reduces anastomotic leak, yet these techniques may 
improve a surgeon’s confidence regarding the strength of 
one’s anastomosis.
Fibrin glues
These topical sealants appear to have the most popularity in 
obesity surgery. However, to date, a randomized study has 
failed to show a decrease in anastomotic leak rate with the use 
of fibrin glue.88 At the same time, there have been a number 
of case series of obesity surgeries published, which had very 
low leak rates with the use of fibrin glues and consequently, 
it has remained popular in this area of the GI anastomosis 
despite a lack of hard comparison evidence.89
Buttressing anastomoses with native 
tissue
There are many different techniques described to buttress 
one’s anastomosis.90,91 These include the use of omentum 
and mesentery. Advocates of these buttressing techniques 
often describe low anastomotic leak rates. No large com-
parative studies are available for GI anastomoses except for 
esophagectomy.87 In the esophagus, omentoplasy of anas-
tomoses has been prospectively evaluated and has lead to a 
decrease in anastomotic leak with an odds ratio of 0.26 in 
metanalysis.87 However, there is no convincing evidence to 
date that this technique results in reduced leak rates of other 
GI anastomoses.
Type of suture material/layers of 
sewn anastomoses
Few studies have evaluated the type of suture material 
utilized or type of sutured construction in GI tract anas-
tomoses. However, in the interest of cost-containment and 
time management, some authors have published their data 
comparing single-layer (either monofilament absorbable 
suture) vs double-layer (classically internal absorbable layer 
and outer interrupted silk suture layer) anastomoses. The 
majority of these studies exclude esophageal and colorectal 
anastomoses. Invariably, the authors have concluded that 
single-layer anastomoses are faster and easier to construct 
with an equivalent complication rate when compared to 
double-layered anastomoses.92–95
Simplification of suturing techniques has become increas-
ingly relevant with the advent and increasing popularity of 
laparoscopic suturing techniques and laparoscopic obesity 
surgery. In keeping with this, a number of recent studies have 
evaluated the utility of utilizing self-locking “barbed” sutures 
to create single-layered upper GI anastomoses. Single-layered 
anastomoses with absorbable “barbed” sutures have been 
found to be more efficient with no increase in anastomotic 
leak rates.96–99
Bowel preparation
The standard preoperative preparation for colorectal surgery 
is to administer oral and mechanical bowel preparation on 
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the day prior to surgery. Over the past decade, this dogma 
has been brought into question. There have been numerous 
studies focused on the risks of bowel preparation and their 
appropriateness and numerous studies have found no evi-
dence that mechanical bowel preparation has an effect on 
anastomotic leak.100–102 Bearing this in mind, recommenda-
tions have been made to avoid mechanical bowel prepping 
patients due to concerns regarding patient satisfaction, poten-
tial electrolyte disturbances, and potential risk of Clostridium 
difficile infection.
Avoidance of mechanical bowel preparation should 
not lead one to delete the oral antibiotic portion of bowel 
preparation, as the digestive tract decontamination with 
oral antibiotics on the day prior to surgery has been clearly 
demonstrated to reduce anastomotic leaks.103 There is actually 
increasing evidence that the makeup and the concentration 
of the intestinal microbiome contributes to anastomotic leak. 
Therefore, reducing the bacterial load rests soundly on the 
basis of scientific data.104 Recently, large NSQIP evaluation 
studies have found a lower incidence of anastomotic leak 
in patients who received combined oral and mechanical 
bowel preparation prior to colon surgery.105,106 Larger pro-
spective studies are certainly needed but, in general, one 
can recommend the use of non-absorbable oral antibiotics 
with/without a mechanical preparation on the day prior to 
colonic surgery.
intraluminal devices
A number of intraluminal devices have been employed in 
an effort to control anastomotic leaks, including stents, 
transanal tubes, and condoms. To date, no large randomized 
studies have clearly demonstrated any advantage to utilizing 
intraluminal devices.107
Reducing ischemia
Ischemia to one’s anastomosis will invariably lead to com-
plications such as leak or stricture. Traditional evaluation 
of viability is based upon palpable pulse, bleeding, and the 
appearance of duskiness. There are newer technological 
advances that are specifically geared toward the evaluation of 
perfusion. Although there are a number of companies working 
on real-time tissue perfusion evaluation, the two main players 
today are Firefly infrared perfusion technology performed 
during robotic surgery (Firefly™, Intuitive Surgical Inc., 
Sunnyvale, CA, USA) and the SPY System (LifeCell Corp, 
Branchburg, NJ, USA). Both of these systems rely on injec-
tion of a fluorescence dye and intraoperative fluorescence 
imaging to evaluate tissue perfusion.
In one study on the use of fluorescence technology intra-
operatively during robotic colectomy, fluorescence imaging 
resulted in a change of the proximal transection location 
in 40% of patients and a 5% change in distal transection 
location.108 A similar recent retrospective evaluation of SPY 
technology resulted in a less modest change in transection 
rate. In this study, two patients had anastomotic leaks and, 
interestingly, they both had well-documented perfusion at the 
time of surgery using the SPY system.109 Although intraopera-
tive perfusion technology is intriguing and appears to give 
a more objective way to evaluate perfusion, to date, there is 
no clear evidence that this technology leads to a lower anas-
tomotic leak rate or has superiority to tradition observational 
evaluations of potentially ischemic tissue.
Resuscitative factors (crystaloid 
administration, hypotension, blood 
loss, and duration of surgery)
Fluid restriction
There is very good evidence in the trauma literature that over-
resuscitation is directly associated with anastomotic leak after 
colectomy.110 On the other hand, there is also evidence that exces-
sive fluid restriction in the operating room also leads to anasto-
motic leakage after GI surgery.111,112 As part of most enhanced 
recovery pathway bundles, goal-directed fluid administration is 
advocated. It is quite likely that this method of fluid administra-
tion will result in a decrease in anastomotic leak but this data 
have yet to be demonstrated. An appropriate fluid administra-
tion that is goal directed should be part of all intraoperative and 
postoperative care following GI surgery.
Hypotension
Most surgeons know well the postoperative implications of 
intraoperative and postoperative cardiopulmonary issues. 
Hypotension is one of these. It has been demonstrated that 
patients with prolonged diastolic blood pressure drops 
have a significantly increased risk of anastomotic leak.113 
Interestingly, the method of treating hypotension may be 
very important. Patients who have postoperative treatment 
with vasopressors have an over three- to fourfold increase 
in anastomotic leak rate and the longer the exposure to 
vasopressors, the higher the risk of anastomotic leak.114,115 
If possible, avoidance of vasopressors is prudent unless they 
are absolutely necessary.
Blood transfusion
Higher blood loss intraoperatively is associated with increased 
anastomotic leak rates.104,116 In addition, blood transfusion in 
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the perioperative period has a very high association with 
anastomotic leak (odds ratio .10).117 Both of these factors 
(blood loss and blood transfusion) may reflect more compli-
cated surgeries with more intraoperative and postoperative 
difficulties. However, one must also consider the immuno-
logic consequences of blood transfusion. Increasingly, we 
are seeing evidence that blood transfusion alone can be a 
risk factor for hospital acquired infections and many have 
concluded that restrictive rather than liberal utilization of 
blood transfusion leads to fewer complications.118
Conclusion
Anastomotic leak remains one of the most relevant complica-
tions following GI surgery. Therefore, it is the obligation of GI 
surgeons to do their best to reduce the risk of anastomotic leaks. 
Unfortunately, despite one’s best efforts, these complications 
are bound to occur and we cannot underestimate the impor-
tance of a high index of suspicion leading to early diagnoses 
of leaks. In addition, we should try to recognize high-risk indi-
viduals and consider the avoidance of anastomosis, proximal 
diversion, and very close observation when possible.
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